• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 11C-PE2I 和 18F-FE-PE2I 对非人类灵长类动物大脑中的多巴胺转运体进行动力学分析和定量。

Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.

机构信息

Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Hospital, Stockholm, Sweden.

出版信息

J Nucl Med. 2011 Jan;52(1):132-9. doi: 10.2967/jnumed.110.077651.

DOI:10.2967/jnumed.110.077651
PMID:21189414
Abstract

UNLABELLED

18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β- (4'-methyl-phenyl)nortropane (18F-FE-PE2I) is a novel radioligand for dopamine transporter (DAT) PET. As compared with 11C-N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(4-methylphenyl)nortropane (11C-PE2I), 18F-FE-PE2I shows faster kinetics and more favorable metabolism, with less production of a radiometabolite with intermediate lipophilicity (M1), which-in the case of 11C-PE2I-has been shown to enter the rat brain. In this study, we compared DAT quantification with 11C-PE2I and 18F-FE-PE2I in nonhuman primates, using kinetic and graphical analysis with the input function of both the parent and the radiometabolite, to assess the potential contribution of the radiometabolite.

METHODS

Three rhesus monkeys were examined with 11C-PE2I and 18F-FE-PE2I using the HRRT system. Arterial input functions of the parent and radiometabolite M1 were measured. Kinetic and graphical analyses were applied using either the parent input (methods 1 and 3) or the parent plus radiometabolite input (methods 2 and 4). Outcome measures were distribution volumes (VT and VND), specific-to-nondisplaceable tissue radioactivity ratio at equilibrium (BPND; parent input), and specific-to-nondisplaceable tissue radioactivity ratio at equilibrium in the presence of metabolites (RT; parent plus radiometabolite input).

RESULTS

11C-PE2I showed higher distribution volumes than 18F-FE-PE2I calculated with methods 1 and 3 (striatal VT, ∼300%; VND in cerebellum, ∼30%). With methods 2 and 4, VT in the striatum was approximately 60% higher in the case of 11C-PE2I, whereas no difference in VND was found in the cerebellum. For each radioligand, BPND estimated with methods 1 and 3 tended to be higher than RT estimated with methods 2 and 4. However, the bias of BPND, compared with RT, was much larger for 11C-PE2I (40%-60% in the caudate and putamen) than for 18F-FE-PE2I (<10% in the caudate and putamen).

CONCLUSION

The direct comparison between the radioligands confirmed that 18F-FE-PE2I shows faster kinetics and more favorable metabolism than 11C-PE2I. The kinetic and graphical analyses with the input function of the parent and radiometabolite showed that the bias in BPND was much lower for 18F-FE-PE2I than for 11C-PE2I and suggested that the lower production of the radiometabolite M1 would make 18F-FE-PE2I more suitable for the DAT quantification. Further studies in humans are necessary to confirm these findings.

摘要

目的

在非人类灵长类动物中,使用放射性配体 11C-N-(3-碘丙-2E-烯基)-2β- 碳甲氧基-3β-(4-甲基苯基)去甲托烷(11C-PE2I)和 18F-FE-PE2I,通过使用母体和放射性代谢物的输入函数的动力学和图形分析,来评估放射性代谢物的潜在贡献,比较多巴胺转运体(DAT)的定量与 11C-PE2I 和 18F-FE-PE2I。

方法

使用高分辨率灵长类动物放射断层扫描仪(HRRT)系统,对 3 只恒河猴进行 11C-PE2I 和 18F-FE-PE2I 检测。测量了母体和放射性代谢物 M1 的动脉输入函数。使用母体输入(方法 1 和 3)或母体加放射性代谢物输入(方法 2 和 4)进行了动力学和图形分析。测量指标为分布容积(VT 和 VND)、平衡时特异性与非特异性组织放射性比值(BPND;母体输入)和存在代谢物时特异性与非特异性组织放射性比值(RT;母体加放射性代谢物输入)。

结果

与方法 1 和 3 相比,方法 2 和 4 计算的 11C-PE2I 的分布容积更高(纹状体 VT,约 300%;小脑 VND,约 30%)。对于每种放射性配体,11C-PE2I 的纹状体 VT 用方法 2 和 4 计算大约高 60%,而小脑 VND 没有差异。用方法 1 和 3 估计的 BPND 比用方法 2 和 4 估计的 RT 更倾向于升高,但与 RT 相比,11C-PE2I 的 BPND 偏差(纹状体的 40%-60%)比 18F-FE-PE2I(纹状体的 <10%)大得多。

结论

放射性配体的直接比较证实,18F-FE-PE2I 比 11C-PE2I 显示出更快的动力学和更有利的代谢。母体和放射性代谢物输入函数的动力学和图形分析表明,18F-FE-PE2I 的 BPND 偏差比 11C-PE2I 低得多,这表明放射性代谢物 M1 的产生较低会使 18F-FE-PE2I 更适合 DAT 的定量。有必要在人类中进一步研究以确认这些发现。

相似文献

1
Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.使用 11C-PE2I 和 18F-FE-PE2I 对非人类灵长类动物大脑中的多巴胺转运体进行动力学分析和定量。
J Nucl Med. 2011 Jan;52(1):132-9. doi: 10.2967/jnumed.110.077651.
2
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.新型多巴胺转运体探针[18F]FE-PE2I的合成、放射性标记及初步体内评估
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4843-5. doi: 10.1016/j.bmcl.2009.06.032. Epub 2009 Jun 13.
3
Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.使用 18F-FE-PE2I PET 对人脑多巴胺转运体进行定量研究。
J Nucl Med. 2012 Jul;53(7):1065-73. doi: 10.2967/jnumed.111.101626. Epub 2012 Jun 11.
4
Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.[(18)F]β-CFT-FE(2β-甲氧基羰基-3β-(4-氟苯基)-8-(2-[(18)F]氟乙基)去甲托烷)作为多巴胺转运体配体的潜力:清醒猴脑的正电子发射断层扫描(PET)研究
Synapse. 2004 Oct;54(1):37-45. doi: 10.1002/syn.20059.
5
Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.正常和帕金森病灵长类动物中多巴胺转运体配体11C-PE2I的解剖学和生化相关性:与6-[18F]氟-L-多巴的比较。
J Cereb Blood Flow Metab. 2001 Jul;21(7):782-92. doi: 10.1097/00004647-200107000-00003.
6
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.帕金森病中¹⁸F -(E)-N -(3 - 碘丙 - 2 - 烯基)- 2β - 碳氟乙氧基 - 3β -(4'-甲基 - 苯基)去甲托烷与多巴胺转运体结合的定量分析
J Nucl Med. 2015 May;56(5):714-20. doi: 10.2967/jnumed.114.152421. Epub 2015 Mar 19.
7
Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies.非灵长类动物中 [18F]FE-PE2I 的简化定量和全身分布:对人体研究的预测。
Nucl Med Biol. 2012 Feb;39(2):295-303. doi: 10.1016/j.nucmedbio.2011.08.004. Epub 2011 Oct 26.
8
Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments.3H标记的N-(3-碘丙-2E-烯基)-2β-甲氧羰基-3β-(4-甲基苯基)降托烷(PE2I)的合成及其与小鼠纹状体膜片段的相互作用。
Appl Radiat Isot. 2007 Mar;65(3):293-300. doi: 10.1016/j.apradiso.2006.09.003. Epub 2006 Nov 1.
9
Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.11C-PE2I正电子发射断层显像在帕金森病性疾病鉴别诊断中的应用
J Nucl Med. 2015 Feb;56(2):234-42. doi: 10.2967/jnumed.114.148619. Epub 2015 Jan 15.
10
Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT.用于单光子发射计算机断层显像(SPECT)中多巴胺转运体成像的超选择性放射性配体[123I]PE2I的评估。
Dan Med Bull. 2011 May;58(5):B4279.

引用本文的文献

1
Correcting bias by accounting for radiotracer clearance in tissue: A validation study with [F]FE-PE2I PET in cross-sectional, test-retest and longitudinal cohorts.通过考虑组织中的放射性示踪剂清除来校正偏差:一项使用[F]FE-PE2I正电子发射断层扫描(PET)在横断面、重测和纵向队列中的验证研究。
J Cereb Blood Flow Metab. 2025 Feb 21:271678X251322407. doi: 10.1177/0271678X251322407.
2
GMP production of [F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport.在TRACERLab FX2 N合成模块上按照药品生产质量管理规范(GMP)生产[F]FE - PE2I,一种用于多巴胺转运体体内正电子发射断层扫描(PET)成像的放射性示踪剂。
EJNMMI Radiopharm Chem. 2024 May 2;9(1):35. doi: 10.1186/s41181-024-00269-9.
3
Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson's Disease.
正电子发射断层扫描成像在帕金森病突触功能障碍中的应用。
Neurosci Bull. 2024 Jun;40(6):743-758. doi: 10.1007/s12264-024-01188-0. Epub 2024 Mar 14.
4
Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection.神经退行性疾病脑PET分析中的挑战与创新:关于部分容积效应、小脑区域研究及参考区域选择的小型综述
Front Neurosci. 2023 Nov 30;17:1293847. doi: 10.3389/fnins.2023.1293847. eCollection 2023.
5
Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers.利用长轴向视野 PET/CT 扫描仪中的 Tikhonov 无模型反卷积对五种不同的 PET 示踪剂进行脑灌注估计。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):707-720. doi: 10.1007/s00259-023-06469-w. Epub 2023 Oct 16.
6
Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [F]FE-PE2I-OH for Translational Dopamine Transporter Imaging.微粒体介导的体外代谢:用于制备用于转化多巴胺转运蛋白成像的 PET 放射性配体代谢物 [F]FE-PE2I-OH 的便捷方法。
ACS Chem Neurosci. 2023 Oct 18;14(20):3732-3736. doi: 10.1021/acschemneuro.3c00458. Epub 2023 Sep 27.
7
[F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study.[F]氟代乙基-PE2I数据与帕金森病病程、分期及强直/运动迟缓评分相关:一项PET放射性配体验证研究。
EJNMMI Res. 2023 Apr 5;13(1):29. doi: 10.1186/s13550-023-00974-7.
8
Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [C]PE2I, [F]FE-PE2I and [C]raclopride PET in healthy individuals.纹状体多巴胺转运体和受体的可利用性与[C]PE2I、[F]FE-PE2I 和 [C]raclopride PET 测量的相对脑血流相关,在健康个体中。
J Cereb Blood Flow Metab. 2023 Jul;43(7):1206-1215. doi: 10.1177/0271678X231160881. Epub 2023 Mar 13.
9
Validation of dynamic [F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [O]HO PET.动态[F]FE-PE2I正电子发射断层显像(PET)用于估计相对局部脑血流量的验证:与[O]HO PET的比较
EJNMMI Res. 2022 Nov 17;12(1):72. doi: 10.1186/s13550-022-00941-8.
10
[F]FE-PE2I PET is a feasible alternative to [I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism.[F]FE-PE2I正电子发射断层扫描(PET)是[I]FP-CIT单光子发射计算机断层扫描(SPECT)的一种可行替代方法,用于临床诊断不明确的帕金森病患者的多巴胺转运体成像。
EJNMMI Res. 2022 Sep 7;12(1):56. doi: 10.1186/s13550-022-00930-x.